Modern Chemotherapy
Vol.2 No.3(2013), Paper ID 34723, 6
pages
DOI:10.4236/mc.2013.23006
CIMAvax®EGF vaccine therapy for non-small cell lung cancer: A weighted log-rank tests-based evaluation
Carmen Viada Gonzalez, Jean-François Dupuy, Martha Fors López, Patricia Lorenzo Luaces, Gisela González Marinello, Elia Neninger Vinagera, Beatriz García Verdecia, Tania Crombet-Ramos
Clinical Trials Department, Center of Molecular Immunology, Havana, Cuba
National Institute of Applied Sciences of Rennes, Rennes, France
National Coordinator Center of Clinical Trial, Havana, Cuba
Clinical Trials Department, Center of Molecular Immunology, Havana, Cuba
Clinical Trials Department, Center of Molecular Immunology, Havana, Cuba
Hermanos Ameijeiras Hospital, Havana, Cuba
Clinical Trials Department, Center of Molecular Immunology, Havana, Cuba;
Clinical Trials Department, Center of Molecular Immunology, Havana, Cuba;
Copyright © 2013 Carmen Viada Gonzalez, Jean-François Dupuy, Martha Fors López, Patricia Lorenzo Luaces, Gisela González Marinello, Elia Neninger Vinagera, Beatriz García Verdecia, Tania Crombet-Ramos et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Gonzalez, C. , Dupuy, J. , López, M. , Luaces, P. , Marinello, G. , Vinagera, E. , Verdecia, B. and Crombet-Ramos, T. (2013) CIMAvax
®EGF vaccine therapy for non-small cell lung cancer: A weighted log-rank tests-based evaluation.
Modern Chemotherapy,
2, 51-56. doi:
10.4236/mc.2013.23006.